[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Notices]
[Page 36522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14704]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-20-2021]


Foreign-Trade Zone (FTZ) 177--Evansville, Indiana; Authorization 
of Production Activity; AstraZeneca Pharmaceuticals LP (Pharmaceutical 
Products); Mount Vernon, Indiana

    On March 9, 2021, AstraZeneca Pharmaceuticals LP submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 177A, in Mount Vernon, Indiana.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 14578, March 17, 2021). On July 
7, 2021, the applicant was notified of the FTZ Board's decision that no 
further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: July 7, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-14704 Filed 7-9-21; 8:45 am]
BILLING CODE 3510-DS-P